Six things to know about melasma treatment
Structured for search, voice, and AI overview extraction. These answers define the safe clinical frame before the detailed medical education begins.
When to see a dermatologist for melasma
Book assessment when pigmentation is symmetric, recurrent, spreading, hormonally linked, or not responding to sunscreen and over-the-counter products. Melasma treatment is safest when the diagnosis is confirmed before any peel, laser, or strong cream is started.
Book now
Brown or grey-brown patches on cheeks, forehead, nose, upper lip, or jawline that persist beyond a few weeks.
Pause self-treatment
Burning, scaling, steroid-cream history, sudden darkening after a facial, peel, laser, or fairness product.
Bring context
Pregnancy, oral contraceptive use, hormonal medication, thyroid history, outdoor work, heat exposure, and prior prescriptions.
Expect typing first
The consultation separates melasma from tanning, PIH, lentigines, lichen planus pigmentosus, and drug-related pigmentation.
Melasma patterns — what the dermatologist is looking for
Melasma often has a recognisable facial distribution, but the same patient can have more than one pattern. Mapping matters because upper-lip, malar, centrofacial, and mandibular melasma can have different triggers and response speeds.
CentrofaciaI pattern
Pigment across forehead, nose, cheeks, and upper lip. This is the classic mask-like pattern patients often describe.
Malar pattern
Cheek-dominant patches that worsen after sun, driving, window exposure, or outdoor activity.
Upper-lip melasma
Frequently mistaken for hair shadow. Visible light and heat control are especially important.
Mandibular pattern
Jawline or lower-face involvement can overlap with other pigment disorders and needs careful examination.
Grey-brown tone
Often suggests deeper or mixed pigment and slower response than light brown surface pigment.
Soft borders
Melasma usually has blended edges rather than the sharply punched-out look of isolated sun spots.
Common melasma facial patterns — and why mapping matters
Why melasma develops and why it keeps relapsing
Melasma is driven by a network rather than one cause. UV, visible light, heat, hormones, vascular activity, genetics, and barrier inflammation all increase melanocyte signalling. The treatment plan works only when the dominant triggers are identified.
Ultraviolet exposure
UVA and UVB both stimulate pigment pathways. Daily commuting and window exposure can maintain melasma.
Visible light
High-energy visible light can worsen melasma in darker skin. Tinted sunscreen addresses this missing layer.
Heat
Kitchen heat, hot yoga, steam, summer travel, and high-temperature work can flare melasma without sunburn.
Hormones
Pregnancy, oral contraceptives, hormonal IUDs, fertility treatment, and perimenopause can influence recurrence.
Genetics
Family history increases susceptibility; treatment can control activity but cannot remove the tendency.
Inflammation
Scrubs, strong acids, bleaching products, and mixed creams inflame the barrier and deepen pigmentation.
Risk factors that shape treatment intensity
Risk factors do not mean melasma will be severe, but they change the safety ceiling. A patient with multiple risk factors usually needs slower escalation, stronger maintenance, and more careful procedure selection.
Fitzpatrick III–V skin
Reactive melanocytes increase PIH risk after irritation, peels, and energy devices.
Pregnancy history
Previous chloasma predicts higher recurrence chance with hormonal shifts and sun exposure.
Outdoor work
Teachers, sales professionals, athletes, drivers, and field workers need practical photoprotection planning.
Heat-heavy routines
Cooking, steam, hot workouts, and summer travel can be overlooked flare drivers.
Mixed-cream use
Steroid or hydroquinone misuse changes barrier health and raises rebound risk.
Prior IPL or aggressive laser
Device-triggered worsening needs stabilisation before any new procedure is considered.
Melasma biology — pigment, vessels, barrier, and relapse memory
Melasma is not just excess colour at the surface. It involves melanocyte overactivity, vascular signals, basement-membrane changes, dermal pigment in some cases, and a relapse tendency. This is why a single cream or one laser session rarely gives durable control.
Melanocyte signalling
Melanocytes produce more melanin after light, heat, hormonal, or inflammatory triggers.
Pigment transfer
Melanin moves into surrounding keratinocytes, making surface patches visible.
Vascular contribution
Some melasma has redness or vascular signalling that makes recurrence more likely.
Barrier sensitivity
Irritated skin sends inflammatory signals that can increase pigment production.
Depth variation
Surface pigment clears sooner; deeper pigment requires patience and conservative choices.
Relapse tendency
Even after lightening, the trigger network can reactivate if maintenance stops.
Hormonal melasma — pregnancy, pills, fertility care, and perimenopause
Hormones do not explain every melasma case, but they are important enough to document carefully. Timing around pregnancy, postpartum changes, oral contraceptives, fertility treatment, hormonal IUDs, thyroid symptoms, and perimenopause can change both the cause and the safe treatment list.
Pregnancy onset
Pigmentation that begins during pregnancy is usually managed conservatively until delivery and breastfeeding context are clear. Sunscreen and gentle barrier care do much of the early work.
Postpartum persistence
Some chloasma fades after delivery; persistent patches need structured assessment, with breastfeeding safety considered.
Oral contraceptives
OCP-linked melasma is not handled by abruptly stopping medication. The dermatologist may coordinate with the prescribing doctor when timing strongly suggests a relationship.
Fertility treatment
Hormonal stimulation can flare melasma. The safest approach is prevention and maintenance rather than aggressive treatment during medically sensitive windows.
Perimenopause
Changing hormone patterns and cumulative sun exposure can overlap. These cases often need both pigment control and skin-quality support.
Documentation
Hormonal history is recorded because relapse prevention is weaker when the trigger timeline is guessed instead of documented.
Pregnancy-safe priorities
When melasma starts during pregnancy, the consultation is deliberately conservative. Many prescription pigment suppressors, oral options, and procedures are deferred or narrowed because fetal and breastfeeding safety comes before cosmetic urgency. The useful work is still substantial: tinted mineral or hybrid sunscreen if tolerated, shade behaviour, heat reduction, gentle cleansing, moisturiser support, avoidance of irritant home remedies, and photography that helps judge whether patches are stabilising after delivery. This prevents the common mistake of doing nothing until the melasma becomes entrenched.
Contraceptive timing without blame
Oral contraceptive or hormonal-device timing is documented carefully but not treated as a reason for abrupt self-discontinuation. The dermatologist looks at when the pigmentation began, whether it worsened after a dose or formulation change, whether the patient has other hormonal symptoms, and how important the medication is for gynaecological or contraceptive reasons. If the link seems strong, coordination with the prescribing doctor is safer than giving skin-focused advice in isolation.
Postpartum and fertility-care planning
Postpartum melasma is often complicated by sleep loss, heat exposure, irregular sunscreen use, breastfeeding safety limits, and patient impatience before social events. Fertility treatment adds another layer because hormonal stimulation may increase susceptibility while medical priorities are outside the skin plan. In both contexts, the plan emphasises prevention, gentle maintenance, and realistic timing. It avoids the emotional trap of promising fast correction during a biologically active window.
Hormone-sensitive relapse prevention
Patients with clear hormone-linked melasma need a prevention plan for predictable transition points: pregnancy planning, stopping or starting OCPs, fertility cycles, postpartum return to work, and perimenopausal treatment changes. The plan may intensify sunscreen discipline and maintenance before the flare rather than waiting until the patch darkens. This is especially important for upper-lip and cheek melasma, where even small relapses are highly visible.
When endocrine review is relevant
Melasma itself does not prove that a patient has a hormonal disorder, and the page does not imply that every patient needs blood tests. Referral or additional evaluation becomes relevant when the history suggests thyroid symptoms, menstrual irregularity, PCOS features, fertility treatment, unexplained sudden onset, or medication changes that sit outside routine dermatology decision-making. The dermatologist’s role is to recognise when pigment care should be coordinated with another clinician instead of giving isolated skin advice.
Counselling without over-correction
Hormonal melasma counselling has to be precise because patients can feel blamed for pregnancy, contraception, or medically necessary treatment. The consultation frames hormones as one contributor in a larger trigger network that also includes light, heat, genetics, barrier injury, and prior irritation. This helps patients make safer decisions: improve controllable triggers, discuss medication questions with the prescribing doctor, and avoid unsupported online claims that promise to balance hormones for skin lightening.
The vascular layer in melasma — why redness and heat matter
Melasma is often discussed only as brown pigment, but many resistant cases have a vascular and inflammatory layer. Redness, warmth, flushing, and heat sensitivity can keep melanocytes active. This does not mean every patient needs vascular treatment; it means the dermatologist should look for this layer before increasing pigment suppressors.
Redness as a clue
Subtle redness across a patch may indicate vascular signalling. If it is missed, stronger bleaching agents may irritate the skin without addressing the flare driver.
Heat sensitivity
Patients who darken after cooking, exercise, steam, or hot weather often need heat management as seriously as sunscreen. This changes advice around routines and procedures.
Topical tolerance
Vascular-reactive skin often tolerates actives poorly at first. Barrier repair, anti-inflammatory choices, and slower introduction reduce the chance of rebound pigment.
Device caution
Any energy device that adds heat must be chosen carefully. Stable pigment and reliable aftercare are required before laser toning is discussed.
Progress reading
A patch can look darker when inflamed even before true pigment has increased. Follow-up distinguishes redness-driven contrast from deeper pigment persistence.
Maintenance implication
If heat and vascular reactivity are major drivers, maintenance includes seasonal and lifestyle planning rather than only a night cream.
Epidermal, dermal, and mixed melasma — why depth changes the plan
How melasma is assessed before a plan is written
A melasma consultation is not a treatment booking. It is a diagnostic visit that records pattern, depth clues, trigger history, prior treatment exposure, pregnancy or hormonal context, skin sensitivity, and the patient’s realistic timeline.
History timeline
When it began, whether it followed pregnancy, pills, travel, a procedure, or a product change.
Pattern mapping
Cheeks, forehead, upper lip, jawline, symmetry, borders, and overlap with other pigmentation.
Wood’s lamp where useful
Selected use for depth clues; not every patient needs it and it is not interpreted alone.
Dermoscopy
Looks for pigment pattern, vascular clues, irritation, follicular sparing, and mimics.
Product audit
Sunscreen, actives, mixed creams, fairness creams, scrubs, facials, and makeup removal are reviewed.
Medical context
Pregnancy, breastfeeding, OCPs, clotting history, thyroid signs, PCOS clues, and current medicines.
Epidermal, dermal, and mixed melasma
Depth is one of the most important treatment variables. It affects timeline, peel selection, laser caution, and how improvement should be judged. Patients often feel treatment has failed when the deeper component is simply slower.
Epidermal melasma
Usually brown, more surface-level, and more responsive to topicals and superficial peels.
Dermal melasma
Often grey-brown, less accentuated on Wood’s lamp, and slower to respond.
Mixed melasma
The common long-standing pattern, with some visible early response and some slow residual pigment.
What depth assessment can and cannot say
Depth assessment is a clinical estimate, not a perfect scan of pigment. A Wood’s lamp may accentuate epidermal pigment, while dermoscopy may show a brown network, grey granules, vascular prominence, follicular sparing, or signs of irritation. These clues help decide how cautious the plan should be, but they are interpreted with history, skin type, prior treatment exposure, and response over time. A patient can have surface pigment that lightens early and a deeper background that remains slower, which is why judging success only from the first few weeks can be misleading.
Epidermal clues
Epidermal melasma is often more sharply brown and may show clearer contrast under examination. It is more likely to respond to disciplined photoprotection, prescription topical cycles, and superficial peels when the barrier is calm. Even in epidermal disease, speed is not the only marker of safety. If the patient develops burning, flaking, or redness, melanocyte activity can increase again and erase gains. The practical goal is steady fading without creating inflammation.
Dermal clues
Dermal pigment tends to look greyer or ashy-brown and may not brighten strongly under Wood’s lamp. It usually needs a longer timeline and a lower appetite for aggressive procedures. The dermatologist explains this early because patients with dermal or mixed melasma often feel disappointed when a surface component improves but a shadow remains. Pushing harder with heat, deep peels, or repeated unsupervised actives can worsen the same cases that require patience.
Mixed-depth decision-making
Mixed melasma is common in long-standing Delhi patients because years of sun, heat, product trials, and intermittent treatment can create layers of pigment behaviour. The plan often starts by treating the epidermal component while protecting the dermal component from irritation. Follow-up photographs then show whether the remaining pigment is fading, stable, vascular, or being reinforced by visible light and heat. This is why the plan may change even when the diagnosis has not changed.
Treatment options matched to melasma stability
The safest melasma plan is staged. The dermatologist first stabilises triggers and barrier health, then introduces pigment-modulating topicals, then considers peels, oral therapy, or laser toning only when the risk-benefit balance is favourable.
Photoprotection foundation
Tinted broad-spectrum SPF, reapplication, shade, clothing, and heat reduction.
Barrier repair
Gentle cleanser, moisturiser, stopping irritants, and reducing inflammation before actives.
Topical cycles
Hydroquinone cycles or non-hydroquinone combinations selected by tolerance and context.
Superficial peels
Used for stable epidermal or mixed melasma, never as a harsh shortcut.
Oral tranexamic acid
Reserved for selected resistant cases after contraindication screening.
Laser toning
A cautious adjunct for stable cases, not routine first-line therapy.
How topical treatment is selected
Topical selection depends on pregnancy or breastfeeding context, skin sensitivity, previous steroid or hydroquinone exposure, depth clues, acne tendency, occupation, and the patient’s ability to use sunscreen consistently. A strong prescription cycle may be suitable for one patient with stable epidermal melasma, while another patient needs azelaic acid, niacinamide, gentle pigment modulators, and barrier repair before any stronger agent. The safest plan avoids stacking multiple acids, retinoids, vitamin C, and pigment suppressors in a way that looks active but leaves the skin inflamed.
When oral treatment enters the discussion
Oral tranexamic acid is not a casual brightening tablet. It is discussed only for selected resistant melasma after medical history is reviewed, especially clotting risk, past thrombosis, smoking status, hormonal medication, migraine history, pregnancy plans, and current medicines. Some patients are better served by topical and photoprotection improvement rather than oral escalation. When oral therapy is considered, the dermatologist explains why it is being used, how long it may be reviewed, what warning symptoms matter, and why it does not replace sunscreen or maintenance.
Why combinations are staged
A combined plan does not mean everything begins on the same day. Melasma often needs a sequence: calm the barrier, correct sunscreen, introduce the main topical, review tolerance, then add a peel, oral option, or device only if the skin is stable. This sequencing protects Fitzpatrick III-V skin from treatment-induced pigmentation. It also makes troubleshooting possible. If a patient darkens after starting five products and a procedure together, no one can tell which part caused irritation.
Maintenance transition after active therapy
Once a prescription cycle has achieved useful fading, the plan should step down rather than stop abruptly or continue indefinitely. Maintenance may use tinted sunscreen, non-hydroquinone pigment modulators, retinoid spacing when tolerated, moisturiser support, and scheduled review. The transition is part of treatment, not an afterthought. It reduces rebound, limits long-term medication risk, and keeps the patient from restarting strong creams every time a patch looks slightly darker after heat or travel.
A realistic 24-week melasma sequence
Sequencing prevents the common mistake of doing everything at once. A plan that starts slowly may look less dramatic on day one but usually produces safer control by month three and better maintenance by month six.
Weeks 0-2: calm and map
The first step is not a strong cream. The dermatologist confirms the pattern, looks for irritation, records pregnancy or hormone context, audits sunscreen, and stops obvious triggers such as scrubs, steroid mixes, or harsh facials. This matters because an inflamed barrier can make even correct melasma medicines behave badly.
Weeks 2-6: build the foundation
Tinted broad-spectrum sunscreen, gentle cleansing, moisturiser, and a selected topical are introduced in a way the patient can actually follow. The plan names the upper-lip, cheek, or forehead areas that need careful coverage, because missed edges often explain partial response.
Weeks 6-12: judge response honestly
At review, the doctor separates true pigment improvement from lighting changes, makeup, redness, or temporary peeling. If the skin is calm and the pigment is moving, the same plan may continue. If burning or darkening appears, escalation is paused before PIH is created.
Month 3-4: add only if stable
Superficial peels, oral tranexamic acid, or laser toning are considered only after stability is proven. Adding everything at once may look decisive, but it hides the cause of irritation and raises risk in Fitzpatrick III-V skin.
Month 4-6: transition out of rescue mode
Once pigment is lighter, the plan shifts from pushing treatment to preserving gains. Hydroquinone cycles, if used, are stopped or rotated; gentler maintenance agents and sunscreen discipline become the main work.
After month 6: prevent predictable relapse
Relapse prevention is planned around summer, travel, pregnancy planning, OCP changes, heat exposure, and treatment fatigue. The patient leaves with rules for early darkening so they do not restart old mixed creams or book a rushed procedure.
How resistant melasma is re-evaluated before escalation
When melasma has not improved, the safest next step is not automatically a stronger cream, deeper peel, or laser package. Resistant melasma is re-evaluated like a clinical problem: diagnosis, depth, triggers, adherence, product tolerance, hormonal context, and previous treatment harm are checked again before the plan is intensified.
Re-evaluation is especially important for patients who have already tried several clinics, salon facials, over-the-counter brightening products, or online routines. By the time they reach a dermatologist, the visible patch may no longer represent untreated melasma alone. It may include irritant dermatitis, post-inflammatory hyperpigmentation, steroid rebound, sunscreen failure, or emotional fatigue from repeated disappointment. Treating that situation as a simple pigment problem can push the patient into another unsafe cycle.
The doctor-led review asks what changed before the melasma worsened, what improved temporarily, what caused burning, and what the patient could realistically maintain. A cream that worked for two weeks and then caused darkening tells a different story from a cream that never changed the patch. A peel that made the face glow for a few days and then darkened the upper lip suggests a different risk profile from a peel that produced steady controlled lightening. These distinctions guide the next step.
Resistant melasma also needs honest separation between treatable activity and residual background colour. Some patients continue to chase the last grey-brown shadow even after the active flare is controlled. At that point, the risk of pushing harder may exceed the benefit. A premium consultation explains what is still active, what may be deeper pigment, what can reasonably be improved, and what should be maintained rather than attacked. That explanation often prevents unnecessary procedures.
Photographs are central in this review because memory is unreliable when a condition changes slowly. Phone selfies vary by angle, lighting, camera processing, and makeup, but they still help if they show the timeline. Clinic photographs, when standardised, help compare the same region over time. The most useful progress note may be that borders are softer, upper-lip contrast is lower, or flares after heat are shorter. These details are more clinically useful than asking whether the patch has vanished.
Another premium distinction is recognising when treatment intensity is not the limiting factor. Many patients assume a stronger medicine is needed because the patch is stubborn. Sometimes the real limiting factor is that the skin cannot tolerate the current routine, the sunscreen lacks visible-light coverage, the patient is in a hormonal transition, or a recent procedure has left the skin reactive. Escalation without identifying the limiter creates risk without solving the cause of resistance.
The review also protects patients from cost escalation that does not match biology. A longer package of peels or device sessions may sound decisive, but melasma is not a simple accumulation problem where more sessions always mean more response. If the pigment is unstable, heat-reactive, or dermal-heavy, the safest investment may be better diagnosis, routine simplification, and maintenance design. Cost discussions become more ethical when the doctor explains what each step is expected to change and what it cannot change.
For Indian skin, resistant melasma is handled with a lower tolerance for inflammation. Fitzpatrick III-V skin can respond beautifully when treatment is staged, but it can also leave darker marks after irritation. The plan therefore includes pause rules, seasonal timing, and conservative procedure thresholds. A patient who has already darkened after IPL, frequent peels, or mixed creams should not be treated as if they are starting from neutral skin.
The end product of re-evaluation should be a written logic, not just a new prescription. The patient should understand why the diagnosis still fits, why the next step was chosen, what needs to happen before escalation, what would make the doctor pause, and how progress will be judged. This level of clarity is what distinguishes a reference-quality melasma page from a list of available treatments.
In resistant cases, the dermatologist also checks whether the patient has been measuring the wrong outcome. A patient may say nothing changed because the central patch remains visible, while photographs show that new flares have stopped, borders are softer, and makeup coverage is easier. That is not complete clearance, but it is clinically meaningful control. Naming those gains helps the patient avoid abandoning a safe plan too early. It also helps the doctor decide whether to maintain, refine, or carefully add an adjunct rather than restarting from zero.
Another common issue is that the patient has received episodic care instead of a sequence. One clinic may prescribe a strong cream, another may add a peel, a salon may add a brightening facial, and an online routine may add acids. Each step may seem reasonable in isolation, but together they can create inflammation, confusion, and poor adherence. Premium re-evaluation rebuilds the sequence so each intervention has a purpose, timing, stop rule, and review point. This is especially important when the patient is emotionally tired and wants the next step to be decisive.
Resistant melasma also needs a medication-safety review. Retinoids, hydroquinone, oral tranexamic acid, acids, and hormonal medicines all have context. Pregnancy planning, breastfeeding, clotting risk, migraine history, smoking, thyroid symptoms, PCOS clues, and recent procedures can change what is appropriate. The page does not ask patients to self-screen these risks; it explains why the dermatologist asks detailed questions before prescribing. That detail protects patients from copying a routine that worked for someone else but is unsafe for their medical situation.
The consultation should also address what will happen if the next step does not work. This is not negative framing; it prevents panic. The patient should know when to send a photo, when to stop an active, when to continue despite slow progress, and when a procedure should be delayed. A plan with if-this-then-that logic feels calmer because the patient is not left guessing after every darker day. That confidence can improve adherence as much as another product.
Complex melasma review also checks whether the patient has been exposed to contradictory advice. One person may have been told to avoid all lasers, another to do monthly laser sessions, another to use hydroquinone continuously, and another to stop sunscreen because they are mostly indoors. Premium care does not simply choose one opinion. It explains the condition-specific reasoning: what is true for unstable melasma, what is true for epidermal melasma, what is true for pregnancy-linked melasma, and what is true for dermal or mixed disease.
The dermatologist also looks for avoidable friction between the plan and the patient’s life. A night routine that stains pillows, a sunscreen that transfers onto work clothes, a peel schedule that conflicts with travel, or a medication plan that ignores breastfeeding will not hold. These practical barriers are not minor. They are the reasons many technically correct plans fail. A premium plan asks about them early so the patient does not silently abandon care.
Some patients need emotional reframing before medical escalation. Recurrent melasma can make people feel that every darker day is a disaster, especially when family, photographs, or social comments focus on complexion. The consultation should validate the burden without using that distress to sell riskier treatment. When the patient understands the chronic nature of melasma, the visible-light role, and the reason maintenance matters, they can make decisions from clarity rather than pressure.
A premium re-evaluation also names uncertainty instead of hiding it. Wood’s lamp, dermoscopy, photographs, and history improve decision-making, but melasma depth and trigger dominance are still clinical estimates. The doctor may therefore choose a reversible step first: repair, observe, introduce one active, then review. This is not hesitation. It is a safer way to learn how the patient’s skin behaves before adding procedures or oral therapy.
The review should also protect patients from comparison anxiety. Another patient’s dramatic response may have involved epidermal pigment, different hormones, different sunscreen adherence, or a shorter history. A slower response does not automatically mean poor care. The relevant comparison is the patient’s own baseline, trigger control, tolerance, and stability. This framing helps patients stay with a safe plan long enough to judge it fairly.
Resistant melasma review should also include the patient’s definition of acceptable maintenance. Some patients are comfortable with nightly medication cycles and regular visits; others need the smallest sustainable routine because work, caregiving, pregnancy plans, or budget make complex care unrealistic. The dermatologist can still build a medically sound plan, but it may prioritise the highest-yield steps: visible-light protection, one well-tolerated active, barrier repair, and clear flare instructions. A plan that is slightly less intensive but consistently followed is often safer than an ideal plan that collapses after two weeks.
First question: is it all melasma?
Brown facial patches can overlap. A patient may have melasma on the cheeks, tanning on the forehead, post-inflammatory hyperpigmentation around acne marks, perioral pigmentation from irritation, and lentigines from chronic sun exposure. If every patch is treated as one disease, the plan becomes too aggressive for some areas and too weak for others. Re-evaluation separates each pattern so the doctor can decide which pigment is expected to fade with topicals, which needs long maintenance, and which should not be treated with melasma protocols at all.
Second question: is depth limiting speed?
Patients often describe treatment as failed when the epidermal component has improved but a dermal or mixed shadow remains. That distinction changes counselling. Surface pigment may lighten within weeks, while deeper pigment can take months and may never clear completely without risking overtreatment. If the remaining pigment is mostly deeper, the plan shifts toward stability, camouflage, maintenance, and cautious adjuncts rather than repeatedly increasing irritation. This protects patients from chasing a shadow with procedures that can make reactive Indian skin darker.
Third question: is sunscreen truly doing the job?
Many resistant cases are not treatment-resistant; they are photoprotection-resistant. The patient may own a good sunscreen but use too little, skip the upper lip, choose an untinted formula, forget reapplication before the commute home, or remove sunscreen by scrubbing. The doctor reviews brand, texture, tint, quantity, timing, and exposure pattern. If visible light and heat continue to stimulate pigment every day, changing the night cream will not solve the relapse loop. Fixing sunscreen is often the highest-yield escalation.
Fourth question: is the barrier quietly inflamed?
Melasma skin can look only mildly dry while still being too irritated for active treatment. Stinging with cleanser, burning after sunscreen, tightness after washing, flaking around the mouth, or redness under makeup all suggest barrier stress. In that setting, adding stronger pigment suppressors may worsen the same pathway being treated. A premium plan may temporarily reduce actives, repair the barrier, and restart more slowly. This can feel like stepping back, but it often makes the next pigment phase safer and more effective.
Fifth question: are old creams still influencing the skin?
Previous steroid or mixed-cream use can distort the current presentation. The skin may be thinner, redder, acne-prone, or more reactive than expected. Hydroquinone misuse can also create grey-brown or blue-grey tones that do not behave like ordinary epidermal melasma. Re-evaluation asks for tube photos, prescription names, duration, frequency, and stopping pattern. Without that history, the patient may be given the same type of medication that caused the problem, only under a different label.
Sixth question: is a hormonal window active?
Resistant melasma around pregnancy, postpartum months, oral contraceptive changes, fertility treatment, or perimenopause may not be failing because treatment is weak. The trigger load may still be high. In these windows, the plan often prioritises prevention, pregnancy- or breastfeeding-compatible choices, and coordination with the relevant doctor when medication questions arise. The dermatologist avoids giving isolated skin advice that conflicts with contraception, fertility care, thyroid evaluation, or postpartum safety.
Seventh question: is heat sensitivity being missed?
Some patients avoid sun but flare after cooking, steam, hot yoga, outdoor exercise, long drives, or device-based facials. Heat-sensitive melasma may darken despite good SPF because the trigger is not only ultraviolet light. The plan then adds practical heat reduction: cooler exercise timing, avoiding steam, careful post-procedure cooling, and choosing sunscreen textures that survive sweating. This is not lifestyle blame; it is matching treatment to the patient’s dominant trigger.
Eighth question: is the routine too crowded?
Resistant melasma patients often arrive with a shelf full of acids, vitamin C, retinoids, pigment serums, masks, and spot creams. A crowded routine can create low-grade irritation that blocks progress. Simplifying is not downgrading care. It removes noise so the dermatologist can see which active helps and which active hurts. A shorter routine also improves adherence, reduces cost, and makes it easier to maintain results after the active phase.
Ninth question: is a procedure being chosen for the wrong reason?
Procedures should answer a clinical question. A superficial peel may help stable epidermal pigment; laser toning may be discussed for selected stable resistant cases; oral therapy may be considered when recurrent or vascular features dominate. If the reason is simply that the patient is frustrated, an event is near, or a package is available, the risk-benefit logic is weak. Resistant melasma needs better selection, not automatic escalation.
Tenth question: what will define success now?
In complex melasma, success may need to be reframed. A fair goal might be fewer summer flares, less upper-lip contrast, safer camouflage, no further steroid rebound, or stable pigment through a travel season. Those are real outcomes. If success is defined only as complete disappearance, the patient may keep accepting risk that the biology does not justify. The doctor’s job is to make the tradeoff clear before the next step begins.
Why this re-evaluation is premium care
Premium melasma care is not the longest prescription. It is the most accurate sequence. Re-evaluation prevents the same patient from receiving repeated peels when the barrier is inflamed, laser when the pigment is unstable, hydroquinone when ochronosis is suspected, or oral therapy when sunscreen is failing. It also gives the patient a clearer story: what is improving, what is still active, what is unsafe to push, and what will be reviewed next. That clarity is often what was missing from previous treatment.
Side-by-side comparison — what each melasma modality does and does not do
This table helps explain why melasma treatment is layered. No single option covers light exposure, hormone sensitivity, surface pigment, deeper pigment, and relapse prevention at the same time.
| Modality | Best role | Limitations | Indian-skin safety note |
|---|---|---|---|
| Tinted sunscreen | Daily foundation; reduces UV and visible-light triggers | Does not remove established deep pigment by itself | Amount, tint, and reapplication decide effectiveness |
| Hydroquinone cycle | Short-term pigment suppression in selected patients | Not for indefinite unsupervised use | Misuse can cause rebound, dermatitis, or ochronosis |
| Azelaic / kojic / arbutin | Supportive or maintenance pigment modulation | Slower than stronger prescription cycles | Useful where irritation risk or pregnancy context limits choices |
| Superficial peels | Surface pigment and texture support | Not suitable on inflamed or unstable melasma | Concentration and interval must be conservative |
| Oral tranexamic acid | Selected resistant recurrent melasma | Requires contraindication screening | Not prescribed casually or as a cosmetic tablet |
| Laser toning | Adjunct in stable resistant cases | Can worsen melasma if aggressive | Low fluence, limited sessions, and careful review are essential |
Topicals used in melasma — selected by role, not trend
Topical treatment is the core of most melasma plans. The question is not which ingredient is famous; it is which role is needed now: suppress pigment production, support turnover, reduce transfer, calm inflammation, or maintain results.
Hydroquinone
Effective short-term tyrosinase inhibition when supervised. Used in cycles with clear stop points, not as an indefinite fairness cream.
Azelaic acid
Useful for reactive skin, PIH overlap, and pregnancy-compatible contexts when prescribed appropriately.
Kojic acid / arbutin
Support pigment suppression with lower intensity than prescription hydroquinone cycles.
Retinoids
Support turnover and texture, but must be introduced carefully to avoid irritation-driven pigment.
Niacinamide
Helps reduce pigment transfer and supports barrier tolerance in layered routines.
Topical tranexamic acid
Useful as part of selected melasma routines, especially where vascular contribution is suspected.
Oral tranexamic acid — useful only after screening
Oral tranexamic acid can help selected patients with resistant melasma, but it is a medical prescription with exclusions. It should never be started from social media advice, salon recommendation, or a borrowed prescription.
When it may be useful
Oral tranexamic acid is usually discussed for recurrent, resistant, or vascular-looking melasma after topical care and photoprotection are already disciplined. It is not used to compensate for poor sunscreen use.
When it is avoided
Personal clotting history, certain family histories, smoking, pregnancy, recent surgery, high-risk hormonal medication contexts, and other medical factors can make oral therapy unsuitable. Screening is a safety step, not paperwork.
What it does not replace
The tablet does not replace tinted sunscreen, barrier repair, or topical maintenance. If visible light and heat continue to stimulate pigment daily, oral treatment has a weaker and less durable effect.
How benefit is judged
Benefit is judged by photographs, relapse frequency, border softening, and reduced flare intensity. The dermatologist also asks about side effects and any change in medical status before continuing.
Why courses are limited
Oral tranexamic acid is not prescribed as an indefinite complexion tablet. A defined course and review point protect the patient from casual long-term use without reassessing risk.
How it is stopped
Stopping is paired with maintenance, not abandonment. The plan usually returns emphasis to sunscreen, non-hydroquinone topicals, and early-flare rules so improvement is not lost immediately.
Laser toning — cautious adjunct, not first-line melasma care
Low-fluence Q-switched Nd:YAG laser toning may help selected stable melasma. The same category of device can also worsen pigment if used aggressively. Patient selection, parameters, intervals, and stop rules matter more than the machine name.
Stable pigment first
Laser toning is discussed only when pigment is not actively worsening, the barrier is calm, and sunscreen adherence is credible. Treating unstable melasma with heat can convert a difficult case into a more reactive one.
Low-fluence logic
The aim is gentle pigment modulation, not dramatic heat injury. Conservative settings and measured intervals matter because Indian skin can darken after excessive energy even when the device is technically appropriate.
Stop rules
Persistent redness, new darkening, mottled light patches, or increased heat sensitivity are reasons to pause. Continuing sessions because a package was purchased is unsafe clinical logic.
Not for recent flares
Recent tanning, dermatitis, aggressive peels, or mixed-cream withdrawal usually push laser later. The skin first needs time to prove that melanocytes are quieter.
Photoprotection after laser
Aftercare is not a printed sheet alone. The patient needs practical visible-light and heat avoidance during the vulnerable window after each session.
Honest endpoint
Laser toning may soften stubborn patches; it is not a permanent eraser. A good endpoint is safer fading with stable maintenance, not chasing every residual shadow.
Chemical peels for melasma — surface support, not a shortcut
Peels can support epidermal melasma and improve surface dullness, but the wrong peel can inflame Indian skin and deepen pigmentation. Preparation and aftercare are part of the peel, not extras.
Prepared skin only
Peels are safer when sunscreen is consistent, the barrier is calm, and the patient can follow aftercare. Peeling inflamed melasma can create darker pigment than the patch being treated.
Superficial depth
Melasma peels are usually superficial and staged. The aim is controlled surface support, not visible injury that proves something strong was done.
Agent selection
Glycolic, lactic, mandelic, salicylic combinations, or other pigment-focused options are chosen by tolerance, acne overlap, sensitivity, and depth clues.
Interval matters
Short intervals can stack inflammation. The review between sessions is as important as the peel because it shows whether pigment is calming or reacting.
Event timing
A peel close to a wedding or travel date is avoided if the skin cannot tolerate downtime. Camouflage plus maintenance may be safer than last-minute exfoliation.
When peels are skipped
Dermal-heavy melasma, active dermatitis, recent sunburn, pregnancy restrictions, or poor sunscreen adherence can make peels a poor use of risk.
What worsens melasma — and why those shortcuts are risky
Most difficult melasma cases have a history of over-treatment, not under-treatment. The skin has been bleached, scrubbed, peeled too often, lasered aggressively, or exposed to mixed creams until the barrier becomes reactive.
Daily scrubbing
Scrubbing creates friction and micro-inflammation. In melasma, that irritation can stimulate pigment even when the skin temporarily looks brighter after exfoliation.
Unlabelled mixed creams
Steroid, hydroquinone, tretinoin, and antifungal combinations can give short-term lightening while creating rebound, acneiform eruptions, thinning, and ochronosis risk.
Heat-heavy facials
Steam, massage friction, fragrance, and brightening acids can flare melasma-prone skin. A facial is not harmless if it adds heat and irritation before an event.
Device shopping
Moving from IPL to laser to stronger laser without diagnosis treats melasma like a removable spot. Diffuse recurrent pigment needs a control plan.
Stopping too early
Stopping sunscreen and maintenance once patches fade lets reactive melanocytes meet the same triggers again. Relapse after early stopping is predictable, not mysterious.
Chasing whiteness
The safe target is less contrast and fewer flares, not changing natural skin colour. Whitening goals often push patients toward unsafe creams and excessive procedures.
Coming off mixed creams safely
Many patients arrive after months or years of glow, fairness, or pharmacy creams. The first job is not always stronger pigment treatment; it may be identifying steroid damage, rebound, dermatitis, or ochronosis risk.
Identify the ingredients
The tube, prescription, or purchase photo helps identify steroid, hydroquinone, tretinoin, antifungal, or unknown combinations. Treatment cannot be safely planned from the word "glow cream" alone.
Check for steroid effects
Redness, acne-like bumps, visible vessels, thinning, and sensitivity change the starting point. The first phase may be steroid withdrawal support rather than pigment suppression.
Look for ochronosis clues
Blue-grey or speckled darkening after long hydroquinone misuse needs careful assessment. More hydroquinone is not the answer when ochronosis is suspected.
Taper when needed
Some patients rebound when a potent mixed cream is stopped abruptly. The dermatologist may taper, calm the barrier, and introduce safer maintenance step by step.
Reset expectations
Mixed creams can create an unrealistic memory of fast lightening. The safer plan may feel slower because it is trying to avoid the same rebound cycle.
Document the baseline
Photographs before withdrawal help separate true worsening from steroid rebound, irritation settling, or lighting differences during recovery.
Melasma myths — and what is actually true
Melasma attracts shortcuts because patients are frustrated by recurrence. Myths usually sound convenient; the reality is safer and slower, but it protects the skin.
When melasma treatment has failed before
A previous failure does not mean melasma cannot improve. It usually means the diagnosis, depth, trigger control, sunscreen layer, treatment strength, procedure choice, or maintenance plan was mismatched. The consultation rebuilds the pathway from the failure pattern rather than simply repeating the strongest previous step.
Cream worked then stopped
This often reflects hydroquinone overuse, no maintenance transition, or trigger exposure returning after early improvement.
Peel caused darkening
The skin may have been inflamed, the peel too strong, or aftercare insufficient for Fitzpatrick III–V reactivity.
Laser made it worse
Heat-triggered rebound is common when melasma is treated like a simple spot-removal problem. Stabilisation comes first.
Nothing changed
Depth may be dermal or mixed, sunscreen may be under-protective, or the routine may not have been used long enough to judge.
Patch moved or spread
New triggers may be active, or the original diagnosis may be incomplete. Dermoscopy and history are repeated.
Confidence dropped
The consultation should address emotional fatigue honestly while still avoiding unsafe promises or rushed procedures.
Reconstructing the old plan
A failed-treatment history is useful only when it is reconstructed precisely. The dermatologist asks for product names, photographs of tubes, duration, frequency, whether the cream was stopped suddenly, whether peeling or burning occurred, what sunscreen was used, and whether the patient was travelling, pregnant, outdoors, or using a facial kit at the same time. Without this reconstruction, a new plan may repeat the same mistake under a different brand name.
Distinguishing non-response from intolerance
Some melasma plans fail because the pigment biology was resistant; others fail because the skin never tolerated treatment long enough to benefit. Redness, itching, flaking, stinging, acneiform bumps, and tightness are not minor inconveniences in melasma. They can be the reason pigment worsens. A patient who says "nothing worked" may actually need a gentler plan, better sunscreen, or recovery from steroid exposure before pigment suppression can work.
Red flags in previous care
Warning signs include unlabeled mixed creams, daily steroid combinations, deep or frequent peels, IPL for diffuse melasma, laser sessions done during active tanning, and packages sold without documenting depth or trigger history. These histories shift the first phase toward diagnosis and stabilisation. They also change counselling because the patient may expect another dramatic short-term lightening cycle even when the skin needs restraint.
How recovery is measured
After a failed plan, success is not measured only by immediate lightening. Early success may mean the skin stops burning, sunscreen becomes tolerable, redness settles, new darkening pauses, and photographs show stable borders. Once the skin is calm, pigment work becomes more predictable. This slower reset is often the difference between another disappointment and a plan that can be maintained safely.
Suitability for melasma treatment
Almost every patient can start some form of safe melasma care, but not every patient is ready for the same intensity. Suitability separates what can start today from what needs delay, investigation, or coordination.
Sequencing melasma treatment around weddings, travel, and festivals
Melasma planning works best with runway. Aggressive treatment right before an event is rarely safer or faster. The dermatologist balances visible improvement with the risk of irritation, peeling, or rebound darkening.
Six months before
This is the safest window for diagnosis, sunscreen correction, topical cycles, and planned reviews. It allows visible change without forcing aggressive treatment close to an event.
Three months before
The plan focuses on consistency: tinted sunscreen, stable topicals, and selected superficial peels only if the skin is calm. New high-risk procedures are avoided.
One month before
Risk tolerance drops. The dermatologist usually avoids starting strong actives, deep exfoliation, or device sessions that could cause irritation before photographs or ceremonies.
Travel exposure
Beach trips, hill stations, flights, driving, and outdoor functions need a photoprotection plan before leaving. Post-travel review matters if pigment darkens.
Makeup strategy
Tinted sunscreen and camouflage can be part of the plan when they do not irritate the skin. Gentle removal is specified so long-wear makeup does not trigger friction.
After the event
Patients often stop care once photographs are over. The follow-up visit prevents the event plan from becoming another relapse cycle.
Why Fitzpatrick III–V skin needs melasma-specific calibration
Indian skin is not unsafe for melasma treatment; it is unsafe to treat it with protocols copied from lighter skin without adjustment. Pigment reactivity changes concentrations, intervals, peel depth, laser fluence, and aftercare.
Lower irritation margin
Fitzpatrick III-V skin often tolerates treatment well when the plan is calibrated, but unnecessary redness can leave a darker footprint. Starting frequency matters as much as ingredient choice.
Visible-light sensitivity
Indian skin can pigment from visible light even when UVB is blocked. This is why iron oxide tint and real-world reapplication are medical decisions in melasma.
Peel depth restraint
Superficial peels may help, but deeper injury can create PIH. The doctor chooses the lightest effective intervention, not the strongest available peel.
Device caution
Laser fluence, pulse choice, interval, cooling, and stopping rules are adjusted to pigment reactivity. Heat-driven rebound is treated as a serious risk.
Barrier-first escalation
If the patient stings with cleanser or moisturiser, actives and procedures are delayed. A reactive barrier is a poor platform for melasma treatment.
Photographs over memory
Standardised photographs reduce over-treatment. Indian skin can look very different under warm indoor light, bright clinic light, and phone flash.
PIH risk changes the treatment ceiling
Fitzpatrick III-V skin can respond well to melasma treatment, but the margin for irritation is narrower. A peel, retinoid, laser session, or aggressive exfoliant that is tolerated by lighter skin can trigger post-inflammatory hyperpigmentation in reactive Indian skin. This does not mean treatment should be weak; it means the ceiling is chosen intelligently. The dermatologist may use lower starting frequency, smaller test areas, longer intervals, extra moisturiser support, and stricter pause rules when burning or redness appears.
Colour contrast and undertone matter
Melasma assessment in Indian skin must account for baseline undertone, tanning, facial shadows, and uneven pigmentation from other causes. A grey-brown upper-lip patch, malar melasma, forehead pigmentation, and tanning can overlap visually. The plan avoids treating every brown area as the same diagnosis. This protects patients from over-peeling normal tan, missing dermal melasma, or applying strong creams widely across skin that only needs photoprotection and barrier repair.
Procedure spacing is part of safety
Indian skin safety is not only about choosing a lower peel strength or laser fluence. It is also about spacing sessions so inflammation has time to settle, checking the skin before each procedure, and cancelling or postponing treatment after recent sun exposure, waxing, dermatitis, illness, or a new active product. A delayed session can be the safest decision. Melasma worsened by a rushed procedure is harder to treat than melasma that improves gradually.
Culturally realistic routines
Many Indian patients use makeup, bindis, scarves, helmets, religious or work-related head coverings, salon services, and seasonal wedding makeup. These details can affect friction, heat, removal routines, and sunscreen adherence. A useful melasma plan works within the patient’s life instead of giving abstract instructions. The dermatologist may suggest sunscreen formats, cleansing methods, and review timing that fit the patient’s daily routine while still protecting the skin.
If this is the dominant issue · Then the plan changes
UVB · UVA · visible light · heat — melasma protection is layered
Delhi heat, pollution, commuting, and melasma flares
Melasma plans need to survive Delhi life. Bright light, long commutes, pollution, heat, outdoor errands, and wedding-season makeup all change how photoprotection and barrier care should be prescribed.
Two-wheeler and car exposure
Short daily commutes can equal a long weekly exposure. The driving side, helmet line, scarf friction, and window light can explain asymmetric persistence.
Cooking and indoor heat
Melasma can flare in patients who avoid direct sun but spend time near kitchen heat. Heat reduction is discussed without turning daily life into an impossible rulebook.
Pollution and barrier stress
Pollution does not replace light as a trigger, but it can increase barrier irritation. Cleansing needs to remove residue without stripping the skin.
Wedding-season routines
Makeup, facials, late nights, travel, and outdoor photography often cluster together. The plan identifies which steps are safe and which should be avoided.
Summer sweat
Sweating can break down sunscreen and make reapplication uncomfortable. Texture, water resistance, and realistic touch-up methods are chosen before summer peaks.
Winter dryness
Dryness can make retinoids and acids sting. Winter maintenance may need more barrier support so treatment does not trigger irritation-driven pigment.
How melasma treatment is calibrated for Fitzpatrick III–V
Safety is built into every step: ingredient choice, starting frequency, peel strength, laser fluence, aftercare, follow-up interval, and pause rules.
Start low, review early
Actives may begin at lower frequency and increase only when the skin is calm. This avoids creating PIH while still allowing meaningful treatment.
Patch history matters
Prior peel burns, IPL worsening, steroid creams, or post-facial darkening lower the threshold for delaying procedures and repairing the barrier first.
One change at a time
Introducing too many products at once makes it impossible to identify the irritant. Controlled sequencing is a safety tool.
Cooling and aftercare
Procedures need cooling, sunscreen, and heat avoidance. Aftercare is part of the treatment, not a courtesy instruction after payment.
Pause rules are written
Burning, swelling, scaling, sudden darkening, or pregnancy changes trigger review. Pausing early prevents a small reaction from becoming a long relapse.
Maintenance is safer than rescue
Repeated rescue cycles are riskier than a quiet maintenance plan. The safest melasma result is stable, not aggressively chased.
How sunscreen has to be used for melasma to respond
Most patients with melasma own sunscreen; fewer use it in a way that protects melasma. The difference between owning SPF and using photoprotection correctly is large. The dermatologist checks product type, tint, amount, reapplication, removal, indoor exposure, and heat behaviour.
Amount matters
A thin cosmetic layer gives less protection than expected. The patient needs a practical quantity that covers face, neck, and upper lip without skipping edges.
Tint matters
Iron oxides help reduce visible light. For melasma in Indian skin, this can be the difference between repeated flares and stable response.
Reapplication matters
Morning sunscreen cannot protect an outdoor commute, lunch exposure, and evening travel unless reapplication is planned realistically.
Windows matter
UVA and visible light through windows can maintain melasma. Desk placement and driving side are relevant clinical details.
Removal matters
Harsh double cleansing can inflame melasma-prone skin. Sunscreen removal should be complete but not abrasive.
Behaviour matters
Hats, shade, umbrellas, scarves, and heat avoidance are not old-fashioned advice; they reduce the trigger load that creams must fight.
Why iron oxides matter in melasma
Many patients choose sunscreen only by SPF, but SPF mainly describes UVB protection. Melasma in Indian skin is also influenced by UVA and visible light, especially high-energy visible wavelengths that can stimulate pigmentation in darker phototypes. Iron oxides are tinting pigments that help reduce visible-light penetration when the product is applied in an adequate layer. This is why a tinted sunscreen may be medically preferable even when an untinted sunscreen has a high SPF. The tint is not makeup advice; it is part of pigment-trigger control.
Matching tint to real use
A sunscreen that looks grey, orange, greasy, or obvious is less likely to be used correctly. The consultation therefore treats texture and shade match as adherence issues, not vanity issues. Some patients need a matte tint for work, some need a moisturising texture because actives are drying, and some need a sweat-resistant option for commuting. The best sunscreen is the one that gives adequate UVA, UVB, and visible-light coverage while still being acceptable enough to apply in the required amount.
Indoor and commute exposure
Melasma can flare even in patients who say they are not outdoors. Window-side desks, long car commutes, two-wheeler travel, market visits, school pick-ups, and terrace chores can add repeated light and heat exposure. The dermatologist asks about the patient’s actual day because a single morning application may fail before the highest exposure period begins. For many Delhi patients, the difference between relapse and stability is a practical reapplication plan for travel and afternoon light, not another stronger night cream.
Common sunscreen failure patterns
Failure often comes from using too little, skipping the upper lip and hairline, choosing untinted sunscreen for visible-light-sensitive melasma, applying sunscreen only on sunny days, relying on SPF in compact powder, or washing it off aggressively at night. Another common problem is using sunscreen correctly during active treatment and then relaxing once patches fade. The maintenance plan names these failure points because relapse often follows behaviour drift rather than a completely new disease process.
Upper-lip and cheek coverage details
Melasma commonly affects the upper lip and malar cheeks, which are also areas patients accidentally under-apply sunscreen to because product collects near the mouth, mask line, moustache area, or smile folds. The dermatologist may specifically ask the patient to demonstrate how sunscreen is applied. Missed borders can explain why a patch fades centrally but remains dark at the edge, or why the upper lip keeps relapsing despite an otherwise disciplined routine.
Photoprotection that survives real days
A working plan accounts for office lights, car windows, cooking heat, school runs, outdoor errands, gym timing, sweating, makeup, and evening commutes. Patients are not simply told to reapply every few hours without context; they are helped to choose practical reapplication points and formats. For some, that means a second tinted layer before leaving work. For others, it means a hat and shade strategy because repeated product layering feels intolerable. The plan succeeds when it is medically sound and usable.
When sunscreen needs changing
A sunscreen that worked during winter may fail during humid commutes or summer sweating. A formula that is elegant indoors may not hold through two-wheeler travel, gym sessions, or long outdoor queues. Melasma review therefore includes permission to change the sunscreen format without changing the whole medical plan. Switching from a cosmetic SPF to a tinted, broad-spectrum, sweat-tolerant option can sometimes stabilise relapse better than adding another active ingredient.
Why reapplication is individualised
Reapplication advice is adjusted to the patient’s exposure map. A teacher on a sunny campus, a driver, a desk worker near glass, and a homemaker exposed to cooking heat do not have the same trigger pattern. Individualising the plan makes sunscreen adherence measurable instead of vague. It also prevents the patient from feeling blamed when a generic instruction was never realistic for their actual day, budget, climate, commute, makeup, sweating, clothing habits, occupational exposure, and skin tolerance.
What melasma treatment can — and cannot — achieve
Melasma treatment can produce meaningful visible change, but honest framing prevents unsafe decisions. The best outcome is usually controlled, lighter, more stable melasma with a maintenance plan.
Lighter patches
Many patients see meaningful lightening when sunscreen, topicals, and trigger control are consistent. The change is usually gradual rather than overnight.
Softer borders
Melasma often improves first by losing sharp contrast. Softer borders can make camouflage easier even before every shadow fades.
Fewer flares
A strong result includes fewer sudden darkening episodes after heat, travel, or hormonal shifts. Stability is a clinical outcome.
Residual shadow
Dermal or mixed pigment may leave a background shadow. Pushing aggressively against that shadow can create more harm than benefit.
No final-clearance promise
The tendency can return when triggers return. Honest counselling protects patients from unsafe packages that sell certainty melasma cannot support.
Maintenance dependence
The result depends on ongoing photoprotection and maintenance. Stopping everything after improvement is the most common way to lose progress.
How real melasma patients usually arrive
Patients rarely arrive with untouched melasma. Most have already tried sunscreen, fairness creams, facials, peels, or devices. These archetypes help explain how the assessment changes.
Pregnancy and breastfeeding context narrow the active toolbox.
Stabilisation comes before considering any new device.
Needs separation from hair shadow and perioral pigmentation.
Barrier repair and taper strategy often come first.
Visible-light and heat gaps are usually the missing layer.
Safe sequencing beats last-minute aggression.
How to make your melasma consultation more productive
A good consultation depends on accurate history. Melasma is often shaped by products, hormones, sunlight, and prior procedures, so details that seem minor can change the plan substantially.
Bring product photos
Photos of creams, sunscreens, peels, and salon products often reveal steroid mixes, duplicate acids, or sunscreen gaps that patients do not recognise by name.
Bring old prescriptions
Past hydroquinone, tretinoin, tranexamic acid, and laser records help the doctor avoid repeating an unsafe or ineffective sequence.
Map the timeline
Pregnancy, OCP changes, fertility treatment, travel, facials, and sudden worsening dates help identify triggers more accurately than memory alone.
Describe daily light
Commute, desk location, cooking heat, outdoor work, and exercise timing change sunscreen advice. The plan needs the real day, not an ideal day.
Share reaction history
Burning from retinoids, peel darkening, IPL worsening, or fragrance sensitivity changes the safety ceiling from the first visit.
Define the goal
Event timing, camouflage needs, pregnancy planning, and tolerance for maintenance help the dermatologist choose a realistic sequence.
Self-care during melasma treatment
Home care is not an afterthought. Melasma outcomes depend on what happens between visits: sunscreen amount, reapplication, heat exposure, product tolerance, and avoiding inflammation.
Sunscreen quantity
The right label fails when the layer is too thin. Patients are taught where they under-apply: upper lip, hairline, jawline, and lateral cheeks.
Gentle cleansing
Removing sunscreen and makeup should not require scrubbing. Barrier injury can keep melasma reactive even when the prescription is correct.
Heat habits
Cooking heat, steam rooms, hot yoga, and outdoor exercise can matter. The plan reduces repeated heat load without giving unrealistic restrictions.
Active spacing
Retinoids, acids, and pigment suppressors are spaced to avoid stinging. More active ingredients do not equal better melasma control.
Early irritation response
Burning, scaling, and redness are not signs that treatment is working. They are reasons to reduce, pause, or review before pigment rebounds.
Routine simplicity
A three-step routine used daily beats a crowded routine used badly. Premium melasma care is precise, not complicated for its own sake.
The product audit — where many melasma plans are won or lost
The product audit is one of the highest-yield parts of melasma consultation. Patients often bring a sunscreen that is not protective enough, a night routine that is too aggressive, or a fairness product that temporarily lightens while creating long-term instability.
Sunscreen label
SPF, PA rating, tint, water resistance, texture, and real use are checked rather than accepting the bottle at face value.
Night actives
Retinoids, acids, vitamin C, and pigment suppressors are reviewed for duplication and irritation risk.
Fairness products
Unlabelled or pharmacy-mixed creams are treated as medical exposure until proven otherwise.
Facial kits
Salon brightening kits often combine exfoliation, fragrance, and heat, all of which can flare melasma.
Makeup removal
Melasma patients can wear makeup, but removal should not require harsh rubbing across patches.
Simplification
A shorter routine used consistently is usually safer than a crowded shelf of unstable actives.
Realistic melasma journey over six months
Melasma progress is usually non-linear. Early improvement can be encouraging, but maintenance quality determines whether results hold. The journey below is a practical expectation, not a fixed schedule.
Baseline visit
The first visit creates the map: diagnosis, depth clues, triggers, product history, photographs, and the first safe prescription sequence.
First tolerance review
The doctor checks whether the skin is calm enough to continue. Irritation is corrected early rather than ignored for a stronger result.
First response review
At 8-12 weeks, progress is judged by photographs and flare history. Softer borders can be as meaningful as lighter colour.
Adjunct decision
If pigment is stable but stubborn, peels, oral therapy, or cautious laser toning may be discussed. If unstable, the plan stays conservative.
Maintenance switch
The active phase steps down before overuse creates problems. Maintenance protects the result without keeping the skin under constant pressure.
Seasonal review
Summer, travel, pregnancy planning, and procedure timing are reviewed before relapse. Melasma care is proactive when possible.
How follow-up decisions are made
Melasma follow-up is where the plan becomes precise. The dermatologist compares photographs, asks about heat and sun exposure, checks irritation, reviews adherence, and decides whether to continue, reduce, rotate, pause, or add a procedural layer.
Continue
If pigment is lightening and the skin is calm, the same plan may continue until the planned review point.
Reduce
If dryness or burning appears, frequency or strength is reduced before inflammation triggers new pigment.
Rotate
Hydroquinone cycles may rotate into non-hydroquinone maintenance to reduce long-term risk.
Pause
Sudden darkening, dermatitis, pregnancy, or unexpected reaction can pause active treatment safely.
Add
Peels, oral therapy, or laser toning are added only after stability and suitability are confirmed.
Maintain
When improvement plateaus, the goal changes from pushing harder to holding the gain safely.
Maintenance and relapse prevention
Maintenance is the part of melasma treatment that protects the work already done. It is not optional after clearing; it is the reason clearing lasts.
Tinted SPF stays daily
Visible-light protection continues after fading. Stopping tint because pigment improved removes the layer that helped control it.
Hydroquinone exits
If hydroquinone was used, it is rotated or stopped according to plan. Long-term unsupervised continuation is not maintenance.
Gentler agents take over
Azelaic acid, niacinamide, topical tranexamic acid, retinoid spacing, or other agents may hold gains depending on tolerance and pregnancy context.
Flare rules are written
The patient knows what to do after early darkening: check sunscreen, reduce irritants, document exposure, and review before restarting old creams.
Seasonal escalation
Maintenance may intensify before summer, travel, or hormonal transitions, then step down when the trigger load falls.
Review prevents drift
Periodic review catches routine creep: too little sunscreen, too many actives, or procedures done elsewhere without melasma precautions.
Relapse prevention as a permanent layer of care
Relapse prevention is not a discouraging message; it is what makes treatment worthwhile. Patients who understand maintenance are less likely to cycle through repeated flares and rescue treatments. The plan changes from clearing pigment to keeping melanocytes quieter.
Summer plan
Before summer, sunscreen texture, tint, reapplication, hats, and heat exposure are reviewed proactively.
Travel plan
Beach, mountain, wedding, and long-drive exposure need different protection tactics and post-travel review.
Hormone plan
Pregnancy planning, OCP changes, or fertility treatment are moments to intensify prevention rather than wait for a flare.
Procedure plan
Peels and laser toning are avoided during unstable periods. Maintenance lowers the risk of procedure-triggered pigment.
Product plan
Maintenance avoids both undertreatment and overtreatment. It keeps useful agents without recreating irritation.
Review plan
Annual or seasonal review catches early darkening when it is easier to calm than a full relapse.
Maintenance is designed before clearance
The strongest relapse-prevention plans are written before the skin has fully faded. Patients should know what changes after the active phase: which prescription stops, which ingredient continues, how often the dermatologist reviews photographs, what to do during travel, and how to respond to early darkening. Without this transition, many patients repeat the same cycle: strong cream, fast improvement, abrupt stopping, sun or heat exposure, relapse, and stronger rescue treatment.
Seasonal calibration in Delhi
Delhi weather changes the trigger load. Summer heat, monsoon humidity, wedding-season makeup, winter dryness, pollution, and outdoor commuting can each affect tolerance and relapse risk. A summer plan may prioritise sweat-resistant tinted sunscreen and heat avoidance, while winter may require barrier repair so retinoids or pigment modulators do not irritate. Seasonal calibration keeps the plan practical rather than pretending the same routine works identically all year.
Early-flare rescue rules
Relapse prevention includes instructions for the first signs of darkening. Patients are advised not to scrub, peel, restart old mixed creams, or book an emergency laser session. The safer response is to check sunscreen use, reduce irritants, restart the agreed maintenance step if appropriate, and schedule review if the patch is spreading. Early restraint can prevent a small flare from becoming a deeper and more expensive relapse.
Maintenance fatigue
Melasma patients often become tired of routines because the condition is chronic and visible. The maintenance plan has to be simple enough to live with: a sunscreen that suits work, a night routine with clear frequency, realistic review intervals, and written reasons for each step. When the plan is too complicated, adherence falls, then relapse is blamed on the disease alone. Good maintenance removes unnecessary products as much as it preserves useful ones.
What we do not do — and why
Clear exclusions protect patients from the most common melasma harms. A clinic that treats every melasma case with the same laser or cream is not practicing diagnosis-led dermatology.
No fairness framing
The clinical goal is reducing melasma contrast, not changing natural skin colour. Fairness language drives unsafe choices.
No same-package laser
Laser is not attached to every melasma plan. It is selected only when stability and risk profile make sense.
No indefinite hydroquinone
Hydroquinone cycles need stop points. Ochronosis risk and rebound are real when patients keep using strong creams unsupervised.
No peel stacking
Frequent peels are not premium care. They can inflame reactive skin and make pigmentation harder to control.
No borrowed prescriptions
A friend’s melasma plan may be unsafe in pregnancy, clotting risk, mixed-cream history, or dermal-heavy pigment.
No certainty selling
Melasma biology is chronic and trigger-sensitive. Responsible care gives ranges, review points, and maintenance rules instead of certainty.
The emotional side of melasma is real
Melasma is visible, recurrent, and often tied to cultural pressure around facial clarity and complexion. A good consultation makes room for the practical and emotional burden without selling unrealistic certainty.
Mirror fatigue
Daily checking under different lights can make progress feel worse than it is. Standardised photographs give a calmer, fairer comparison.
Complexion pressure
Patients may arrive after being sold fairness products or feeling judged socially. The consultation separates medical pigment control from colourism-driven promises.
Event anxiety
Weddings and photographs can push patients toward risky quick fixes. The doctor’s job is to protect the skin while still addressing the timeline honestly.
Relapse frustration
Relapse can feel like personal failure. In melasma, it usually means triggers returned or maintenance drifted, not that the patient did something wrong.
Camouflage as care
Safe camouflage can reduce distress while treatment works. It is not giving up; it is a practical bridge during a slow medical condition.
Shared decision-making
Some patients prefer slower low-risk care; others accept selected procedures after counselling. Premium care makes tradeoffs explicit.
What makes DDC different for melasma
Melasma is easy to market and easy to mishandle. DDC’s approach is built around diagnosis, conservative escalation, Indian-skin safety, and long-term control rather than device-first packages.
Diagnosis before modality
Melasma is typed by pattern, depth clues, and trigger history before treatment selection.
Visible-light planning
Tinted sunscreen, amount, reapplication, and heat exposure are treated as core therapy.
Indian-skin calibration
Peels, actives, and lasers are adjusted for Fitzpatrick III–V reactivity.
Risk screening
Pregnancy, breastfeeding, clotting history, and medication context change prescriptions.
Product audit
Mixed creams, fairness products, and harsh routines are actively identified.
Timeline honesty
Response is reviewed at realistic intervals, not promised in one sitting.
Written plan
Patients leave with sequence, stop rules, and maintenance instructions.
Maintenance culture
Relapse prevention is built from day one rather than added after recurrence.
How DDC melasma treatment is run behind the scenes
Melasma safety depends on operational discipline: who assesses, who prescribes, how parameters are documented, how reactions are handled, and how progress is measured.
Named reviewer
Medical content and treatment philosophy are reviewed by a qualified dermatologist.
Doctor-led decisions
Reception and non-medical staff do not choose peels, lasers, or prescriptions.
Parameter records
Device settings, peel choices, and skin response are documented for continuity.
Escalation rules
Unexpected darkening, allergy, or irritation triggers dermatologist review and plan adjustment.
Consent and education
Patients are told realistic benefits, risks, downtime, and alternatives before procedures.
Follow-up discipline
Plans are revised from response data, not continued blindly.
Pregnancy safety
Pregnancy and breastfeeding status are checked before restricted medications.
No photo manipulation claims
Images are educational and supportive, not predictive proof.
What melasma before-and-after photos can prove — and what they cannot
Melasma photographs can show change, but they can also mislead when lighting, makeup, filters, or exposure differ. Honest photo use is part of medical ethics.
Useful proof
Same lighting, angle, distance, expression, and no makeup can show real pigment change.
Weak proof
Different brightness, filters, wet skin, flash changes, or makeup can exaggerate improvement.
Not predictive
Another patient’s response does not predict your depth, triggers, or relapse tendency.
Timeline matters
A photo after two weeks means something different from a photo after six months.
Maintenance context
Photos should say whether improvement was maintained or still in active treatment.
Your baseline wins
Your own standardised photos are the best measure of progress.
What happens when melasma is hidden, scrubbed, or treated too aggressively
Melasma is not dangerous in the way a cancer warning lesion is dangerous, but mistreatment can create real harm: deeper pigment, dermatitis, steroid damage, ochronosis, patchy lightening, and years of frustration. The safest plan prevents avoidable injury while improving visible contrast.
Irritant dermatitis
Strong actives or home remedies can inflame the barrier. Inflamed melasma often looks darker and becomes less tolerant of treatment.
Steroid damage
Undisclosed steroid creams can thin skin, create redness, trigger acneiform eruptions, and produce rebound pigmentation when stopped.
Ochronosis risk
Chronic unsupervised hydroquinone misuse can cause blue-grey pigmentation that is difficult to reverse.
Patchy hypopigmentation
Repeated aggressive laser can create uneven light patches that are harder to camouflage than the original melasma.
Financial exhaustion
Repeated packages without diagnosis waste time and money. A written sequence helps stop random escalation.
Delayed proper care
The longer the skin is irritated, the longer the stabilisation phase may need to be before active treatment resumes.
Laser toning is not a shortcut
Low-fluence laser toning may have a role in selected stable melasma, but it is not a universal first-line treatment and not a rescue for poorly controlled triggers. Heat, repeated sessions, high expectations, and weak photoprotection can create rebound pigmentation or mottled lightening. A cautious dermatologist first asks whether the patient has stable pigment, a reliable tinted sunscreen habit, calm skin, no recent tanning, and a clear understanding that results are gradual and maintenance remains necessary.
Why prior laser worsening changes the plan
If a patient darkened after IPL, aggressive laser, or frequent toning, the next step is not simply changing the machine. The case is treated as heat-sensitive until proven otherwise. The dermatologist reviews settings if available, the interval between sessions, whether peels or actives were combined, and what aftercare was used. Many such patients need a cooling-off period with barrier repair and topical control before any device is reconsidered.
Laser suitability checkpoints
Before laser toning is discussed, the plan checks diagnosis, pattern, depth, recent sun exposure, tendency to PIH, pregnancy status, medication history, active dermatitis, and patient ability to attend reviews. The dermatologist also defines stopping rules: if pigment darkens, redness persists, or patches become mottled, escalation is paused. This protects patients from continuing a device course simply because sessions were prepaid.
What the page does not imply
The presence of laser toning on a melasma page does not mean every melasma patient should receive it. It does not replace sunscreen, it does not erase hormonal susceptibility, and it is not equivalent to treating a tattoo or discrete freckle. For some patients, the safest and most effective plan is no device at all until the pigment has remained stable through a season of maintenance.
How device response is judged
Laser response is judged by more than whether the patch looks lighter under clinic lighting. The dermatologist checks redness duration, heat sensitivity, boundary sharpness, mottling, patient photographs in ordinary light, and whether the improvement persists between sessions. If pigment fades briefly and then rebounds darker, the plan is failing even if the immediate post-session appearance looked encouraging. This is why review intervals and conservative endpoints matter in melasma more than dramatic same-day change.
Combining laser with topical care
When laser toning is used, it is usually an adjunct to photoprotection, topical control, and maintenance. The surrounding routine may be simplified before and after sessions so that irritation from retinoids, acids, or exfoliation does not overlap with device heat. Patients are also told what to avoid after treatment: sun exposure, heat procedures, harsh facials, waxing over treated areas, and self-starting strong brightening products. The device session is one part of a controlled plan, not an isolated beauty appointment.
The maintenance playbook for visible light, heat, and real life
Melasma maintenance succeeds when it survives ordinary days. A plan that works only in a clinic explanation will fail during commuting, cooking, sweating, makeup, festivals, travel, and seasonal heat. The maintenance playbook turns photoprotection into a practical routine instead of a vague instruction to use sunscreen.
Visible-light maintenance is where many technically correct melasma plans succeed or fail. A patient may use prescription cream exactly as written but still relapse because the morning sunscreen is untinted, under-applied, or gone by the evening commute. Another patient may buy an excellent tinted sunscreen but use a pea-sized amount to avoid heaviness. The label is only the starting point. The clinical question is whether the product protects the patient’s actual exposure pattern.
Iron oxide tint is often misunderstood as makeup. In melasma care, tint can be part of medical photoprotection because it helps reduce visible-light exposure. This is particularly relevant for Indian skin, where visible light can stimulate pigmentation. The practical challenge is matching the tint to skin tone and routine. If the product looks grey, orange, cakey, or too shiny, the patient will avoid the correct amount. A dermatologist who asks about appearance and comfort is not being cosmetic; they are protecting adherence.
Heat maintenance is equally practical. Patients cannot stop cooking, commuting, exercising, attending weddings, or living in Delhi weather. The plan therefore identifies avoidable heat peaks rather than giving impossible rules. Someone who flares after hot yoga may shift timing or cool down sooner. Someone who cooks daily may improve ventilation and avoid standing directly over steam. Someone who travels by two-wheeler may need a combined shade, helmet, scarf, and reapplication strategy that does not rub the same cheek patch repeatedly.
Maintenance also needs social realism. Many patients want to wear makeup for work, events, or confidence. Forbidding makeup can make the plan less usable. The safer approach is to choose non-irritating camouflage, keep sunscreen as the base layer, avoid harsh removal, and watch for fragrance or long-wear formulas that trigger irritation. The patient should not have to choose between medical care and feeling presentable during a slow condition.
The plan changes around seasons. Summer usually needs sweat tolerance, earlier reapplication, and more physical shade. Monsoon humidity may make heavy products unbearable. Winter may make retinoids and acids more irritating, requiring moisturiser support and fewer active nights. Wedding season can combine makeup, late nights, heat, outdoor photographs, and salon treatments. Maintenance is premium when it anticipates these patterns instead of reacting after every flare.
Early-flare instructions are one of the most useful parts of maintenance. Patients should know what not to do when a patch looks darker: do not scrub, do not restart old mixed creams, do not book an emergency aggressive peel, and do not add three brightening products at once. The safer first steps are to check sunscreen use, reduce irritants, document recent exposure, calm the barrier, and review if the flare persists or spreads. These rules prevent panic from becoming injury.
Maintenance must also respect budget. A plan that depends on multiple expensive serums, frequent procedures, and a sunscreen the patient cannot afford to use generously will fail. The dermatologist may prioritise one reliable tinted sunscreen, one tolerable maintenance active, and one moisturiser over a crowded premium shelf. Effective melasma care is not measured by how many products appear in the routine; it is measured by how reliably the key triggers are controlled.
The final maintenance test is whether the patient can live with the plan for months. Melasma is not managed by a burst of discipline followed by abandonment. It needs a routine that can survive work, family responsibilities, weather, travel, and treatment fatigue. When the plan is specific, realistic, and reviewed periodically, the patient is less likely to bounce between rescue treatments and more likely to hold the gains already achieved.
A good maintenance plan also explains what normal variation looks like. Melasma can look darker after a hot day, poor sleep, heavy makeup, or different lighting without meaning that the entire treatment has failed. Patients who know this are less likely to scrub, panic, or restart old creams. The review focuses on patterns: whether darkening persists, whether borders are spreading, whether irritation is present, and whether recent exposure explains the change. This turns maintenance into observation rather than anxiety.
Visible-light care is also affected by architecture and work style. A patient seated beside a glass wall, driving long distances, teaching outdoors, or visiting construction sites has a different exposure map from someone working away from windows. The maintenance plan may change desk position, commute reapplication, hat use, or sunscreen texture. These adjustments sound small, but melasma often relapses from repeated small exposures rather than one dramatic sunburn.
For patients who wear masks, helmets, scarves, or religious head coverings, friction and heat can overlap with light exposure. The goal is not to stop these items; it is to reduce avoidable rubbing, trapped sweat, and product breakdown. The dermatologist may advise a more transfer-resistant sunscreen, gentler cleansing, and careful moisturiser placement. These details make the plan respectful and usable rather than generic.
Maintenance after procedures is stricter because the skin is temporarily more vulnerable. Even a superficial peel or conservative laser session can fail if the patient resumes heat exposure, strong actives, or inadequate sunscreen immediately afterward. The written plan should state which actives to pause, when to restart, what symptoms require review, and how to protect the skin during commuting. Procedure quality includes the week before and after, not only the minutes inside the treatment room.
Finally, maintenance should be reviewed when life changes. Pregnancy planning, stopping or starting oral contraceptives, fertility care, a new outdoor job, relocation, wedding season, or a long trip can all change relapse risk. Patients do not need to wait for a major flare before asking for adjustment. The best melasma care is anticipatory: it modifies the plan before predictable triggers overwhelm the skin.
Maintenance instructions also need to be written in patient language. “Use sunscreen” is not enough. The plan should say which type, where to apply carefully, when to reapply, what to do if sweating breaks it down, and how to remove it without rubbing. “Continue actives” is also not enough. The plan should say which nights, what irritation means, and what should be paused before a peel, laser session, pregnancy possibility, or unexpected dermatitis.
Review visits are the safety net for maintenance. They catch patients who are doing too little, but also patients who are doing too much. Over-maintenance is common in motivated patients: extra acids, extra retinoid nights, frequent salon clean-ups, or multiple brightening serums stacked over a prescription. The doctor’s role is to keep the plan effective without letting enthusiasm create inflammation. In melasma, restraint is often the more advanced decision.
The best long-term outcome is not a patient who depends on emergencies. It is a patient who understands their triggers, recognises early flare signs, owns a practical sunscreen strategy, and knows when to ask for review. That kind of control is less dramatic than a before-after promise, but it is more medically honest for a condition that can relapse. It is also the reason premium melasma care spends so much time on maintenance rather than only listing procedures.
Maintenance is also where doctor-led care remains relevant after the prescription is written. Patients may add a new serum, change sunscreen because of cost, start gym sessions, travel, begin hormonal medication, or receive a salon peel without realising these changes affect melasma risk. Follow-up gives the dermatologist a chance to update the plan before a small routine change becomes a flare.
The maintenance plan should leave room for patient preference. Some patients want the lowest-risk routine even if fading is slower. Others accept selected procedures after they understand limits and aftercare. Both choices can be reasonable when the tradeoffs are explicit. The page’s role is to make those tradeoffs visible: speed versus irritation risk, procedure benefit versus heat sensitivity, and active treatment versus long-term stability.
The best maintenance conversations are specific enough to prevent accidental escalation. If a patient knows that mild dryness means reduce active frequency, but spreading darkening means review; that travel requires extra tinted sunscreen, but not emergency peeling; and that a new brightening product should be checked before use, the plan becomes safer outside the clinic. Melasma care is mostly lived between appointments. Premium care gives the patient decision rules for that space.
Those rules also make treatment more humane. Patients with melasma often feel they must be perfect every day or the condition will return. A practical plan avoids that burden. It identifies the highest-risk moments, gives recovery steps for imperfect days, and makes review normal rather than shameful. The aim is not to make the patient anxious about every ray of light or every warm kitchen. The aim is to reduce repeated trigger load enough that medical treatment can work and maintenance can hold.
This is also why the page keeps returning to diagnosis before treatment. Melasma care becomes safer when each choice has a reason: tinted sunscreen for visible light, barrier repair for irritation, topical cycles for pigment signalling, peels for selected surface support, oral therapy for carefully screened resistant patterns, and laser toning only when stability justifies the risk. The more clearly the reason is stated, the less likely the patient is to drift into random escalation. Clear reasoning also helps families understand why slower care may be safer than dramatic shortcuts, especially before events, travel, seasonal flares, pregnancy planning, or previous treatment irritation, when pressure for speed is high and skin tolerance may be low.
Morning layer: enough product, not just any product
The morning layer needs broad-spectrum protection, visible-light coverage when appropriate, and a quantity that actually covers the face. Many patients apply sunscreen like moisturiser, leaving thin areas over the upper lip, cheek edges, jawline, and hairline. Melasma often persists exactly in these missed areas. The dermatologist may adjust product type so the patient can use enough without feeling greasy or ashy. This is a medical adherence decision, not a cosmetic preference.
Iron oxide tint: why shade match matters
Iron oxides help reduce visible light, but a tint that looks unnatural will be underused. Shade match matters because adherence matters. Some patients need a warmer tint, some need a matte finish for humid days, and some need a moisturising base because active treatment dries the skin. If the sunscreen is socially uncomfortable, the patient will apply too little or stop using it. The plan treats comfort as part of treatment design.
Reapplication: map it to exposure, not the clock alone
Generic reapplication advice is easy to ignore because every day is different. The plan identifies exposure points: school drop-off, metro walk, two-wheeler ride, car commute, lunch errand, terrace work, gym exit, or drive home. Reapplication is then placed before the exposure that matters most. Some patients need a second full layer; others need a practical tinted touch-up plus hat or shade. The goal is a routine the patient can repeat without resentment.
Makeup and sunscreen: order and removal matter
Makeup is not banned in melasma care. It may improve confidence and, when pigment-safe, can add visible-light coverage. The problem is when makeup replaces sunscreen, requires harsh rubbing at night, or contains irritating fragrance and brightening actives. The doctor may advise sunscreen first, then compatible camouflage, then gentle removal. This protects both emotional comfort and barrier health.
Cooking heat and indoor triggers
Some patients flare while believing they are protected because they spend most of the day indoors. Cooking heat, window light, ironing, hot appliances, and indoor exercise can still add trigger load. The plan may include ventilation, distance from high heat, cooling breaks, and a sunscreen texture that remains tolerable indoors. This advice is kept practical because patients cannot stop living normal lives to manage melasma.
Commute planning in Delhi
Delhi commuting can combine UV, visible light, heat, dust, helmet friction, scarf friction, and sweating. A patient who applies sunscreen at 8 am may be unprotected by the evening commute. The plan may include a reapplication before leaving work, physical shade, a helmet or scarf strategy that avoids rubbing the same cheek patch, and cleansing that removes dust without stripping. These small details often decide whether treatment holds.
Summer escalation before the flare
Maintenance should intensify before summer darkening, not after. The dermatologist may review sunscreen texture, switch to a more sweat-tolerant tinted option, adjust actives if irritation is rising, and plan earlier follow-up. This is especially important for patients with predictable May-June worsening. Treating the flare after it is established usually requires more medication than preventing part of it.
Winter barrier protection
Winter can look safer because sunlight feels weaker, but dryness can make retinoids, acids, and pigment suppressors sting. Irritated skin then becomes more pigment-reactive. Winter maintenance may need richer moisturiser, fewer active nights, and continued visible-light protection near windows and during outdoor events. Seasonal adjustment prevents a plan that worked in one weather pattern from failing in another.
Travel rules that prevent panic treatment
Travel exposes patients to sun, heat, altered sleep, sweating, and missed routines. A travel plan includes enough sunscreen, a tint that can be reapplied, hats or shade, gentle cleanser, moisturiser, and instructions for what to do if pigment darkens. The safest response to post-travel darkening is not a sudden peel or old mixed cream. It is review, barrier calm, and measured re-entry into treatment.
Procedure weeks need stricter maintenance
Peels and laser toning, when used, create windows when the skin needs extra protection. The dermatologist may simplify actives before and after, restrict heat exposure, and emphasise tinted sunscreen and cooling. Procedure aftercare is not optional because melasma responds to inflammation. A technically correct procedure can still fail if the surrounding week is unmanaged.
The maintenance test
A maintenance plan is good only if the patient can explain it back: what to use every morning, when to reapply, what to avoid during flares, when to pause actives, and when to call for review. If the patient leaves with a long list but no decision rules, relapse is more likely. The premium standard is a plan that is medically sound, behaviourally realistic, and specific enough to guide the next ordinary day.
Specialist dermatologists — qualified, registered, experienced
All DDC doctors hold formal medical qualifications and registration. Melasma treatment decisions are made under dermatologist governance because medication choice, procedure intensity, and relapse prevention are medical decisions.
Dr Chetna Ghura
MBBS, MD Dermatology · 16 years experience
Dr Kavita Mehndiratta
Dermatology consultation and procedural suitability review
Dr Sachin Gupta
Clinical governance and protocol review
Dr Aakansha Mittal
Dermatology and aesthetic medicine consultation support
Dr Rinki Tayal
Clinical dermatology review for pigmentary concerns
Starting from ₹1,999 — final cost depends on your plan
Pricing is not packaged because melasma severity, depth, medication needs, peel suitability, laser suitability, and follow-up frequency vary. The consultation creates a written plan and cost discussion.
Consultation includes
History, examination, product audit, trigger review, photography, and written plan.
Cost variables
Topicals, investigations, peels, oral medication, laser toning, and follow-up frequency.
No fixed final price
A stable topical-only case and a resistant mixed melasma case should not be priced as the same package.
Discussed before starting
You should understand sequence and cost before committing to active treatment.
Glossary of melasma terms
Quick reference for terms used on this page and in consultation notes.
- Melasma
- A chronic, relapsing facial pigmentation disorder influenced by light, heat, hormones, genetics, and inflammation.
- Chloasma
- Melasma that appears or worsens during pregnancy; treatment choices are more conservative.
- Epidermal pigment
- Pigment closer to the surface, often more responsive to topicals and superficial peels.
- Dermal pigment
- Deeper pigment that usually improves slowly and requires cautious procedural decisions.
- Mixed melasma
- Melasma with both epidermal and dermal components; common in established cases.
- Melanocyte
- The pigment-producing cell that becomes overactive in melasma.
- Melanin
- The pigment that gives skin colour and creates visible patches when overproduced.
- Tyrosinase
- A key enzyme in melanin production; many topical agents target this pathway.
- Hydroquinone
- A prescription pigment suppressor used in supervised, time-limited cycles.
- Azelaic acid
- A pigment-modulating and anti-inflammatory topical used in selected melasma routines.
- Kojic acid
- A topical tyrosinase inhibitor used as part of combination pigment care.
- Arbutin
- A gentler pigment-modulating ingredient used in selected maintenance plans.
- Niacinamide
- A barrier-supportive ingredient that can reduce pigment transfer.
- Retinoid
- A vitamin-A-derived topical that supports turnover but can irritate if introduced too fast.
- Tranexamic acid
- A topical or oral agent used selectively in melasma, especially resistant patterns.
- Wood’s lamp
- A light-based examination tool that can help assess pigment depth in selected cases.
- Dermoscopy
- Magnified skin examination that helps identify pigment pattern, vascular clues, and mimics.
- Visible light
- Part of the light spectrum that can worsen melasma in darker skin types.
- Iron oxides
- Tinting ingredients in sunscreen that help reduce visible-light exposure.
- Broad-spectrum sunscreen
- Sunscreen that protects against both UVA and UVB.
- SPF
- A measure mainly related to UVB protection; it does not fully describe melasma protection.
- PA rating
- A UVA protection rating used on many sunscreens.
- Photoprotection
- The complete strategy of sunscreen, shade, hats, clothing, reapplication, and heat reduction.
- Barrier repair
- Restoring skin tolerance before stronger actives or procedures.
- Rebound pigmentation
- Darkening that occurs after irritation, abrupt stopping, or inappropriate treatment.
- Exogenous ochronosis
- Blue-grey pigmentation caused by chronic unsupervised hydroquinone misuse.
- Laser toning
- Low-fluence Q-switched laser approach used cautiously in selected stable melasma.
- Chemical peel
- Controlled exfoliation procedure; only superficial, selected peels are used for melasma.
- Maintenance therapy
- Lower-intensity long-term care that helps prevent relapse.
- Fitzpatrick type
- A skin phototype scale; Indian patients often fall in III–V, affecting PIH risk.
Honest answers before you book
Common questions about melasma diagnosis, sunscreen, topicals, peels, laser toning, pregnancy context, maintenance, and Indian-skin safety.
Can melasma be cured permanently?
What is the best melasma treatment in Delhi?
Why does melasma come back after treatment?
Why is tinted sunscreen recommended for melasma?
Is sunscreen alone enough?
What is the difference between epidermal, dermal, and mixed melasma?
Do I need a Wood’s lamp examination?
How does dermoscopy help in melasma?
Can pregnancy trigger melasma?
Can oral contraceptive pills trigger melasma?
Is hydroquinone safe for melasma?
How long can hydroquinone be used?
What are non-hydroquinone options?
What is oral tranexamic acid used for?
Are chemical peels safe for melasma?
Is laser toning safe for melasma?
Why can IPL or aggressive lasers worsen melasma?
How long does melasma treatment take?
Can melasma be treated while breastfeeding?
What if I used a mixed cream or fairness cream?
Can melasma improve before a wedding?
Does diet remove melasma?
What if I also have post-inflammatory hyperpigmentation?
How much does melasma treatment cost?
When should melasma treatment be paused?
Can men get melasma?
Why does melasma look worse in summer?
Can makeup be used during melasma treatment?
Is melasma the same as pigmentation?
How is progress measured?
What happens after melasma improves?
Can home remedies help melasma?
Does stress cause melasma?
Public reference layer — melasma
This page draws on recognised dermatology references for educational accuracy. It does not reproduce clinical guidelines verbatim and does not constitute personal medical advice.
- 1Sheth VM, Pandya AG. Melasma: a comprehensive update. Journal of the American Academy of Dermatology. 2011;65(4):689-718.
- 2Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update. Indian Dermatology Online Journal. 2014;5(4):426-435.
- 3Rendon M, Berneburg M, Arellano I, Picardo M. Treatment of melasma. Journal of the American Academy of Dermatology. 2006;54(5 Suppl 2):S272-S281.
- 4Ortonne JP, Arellano I, Berneburg M, et al. Ultraviolet radiation and hormonal influences in melasma. Journal of the European Academy of Dermatology and Venereology. 2009;23(11):1254-1262.
- 5Lakhdar H, Zouhair K, Khadir K, et al. Broad-spectrum sunscreen in melasma prevention. JEADV. 2007;21(6):738-742.
- 6Mahmoud BH, Hexsel CL, Hamzavi IH, Lim HW. Effects of visible light on the skin. Photochemistry and Photobiology. 2008;84(2):450-462.
- 7Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, et al. Iron oxide-containing sunscreen for melasma. Photodermatology Photoimmunology and Photomedicine. 2014;30(1):35-42.
- 8Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Oral tranexamic acid for melasma: a review. Dermatologic Surgery. 2018;44(6):814-825.
- 9Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched Nd:YAG laser for facial melasma in Asians. Dermatologic Surgery. 2010;36(1):76-87.
- 10Kim EH, Kim YC, Lee ES, Kang HY. Vascular characteristics of melasma. Journal of Dermatological Science. 2007;46(2):111-116.
- 11Verallo-Rowell VM, Verallo V, Graupe K, et al. Azelaic acid and hydroquinone in melasma. Acta Dermato-Venereologica Supplementum. 1989;143:58-61.
- 12Kang HY, Bahadoran P, Ortonne JP. Reflectance confocal microscopy for pigmentary disorders. Experimental Dermatology. 2010;19(3):233-239.
- 13American Academy of Dermatology. Melasma patient education and dermatology resources. Available at: aad.org.
- 14Indian Association of Dermatologists, Venereologists and Leprologists. Pigmentary disorder safety context for Indian skin.
- 15DDC clinical governance: melasma treatment content reviewed by named dermatologist; registration details publicly verifiable.
Get your melasma typed before choosing treatment
The next step is not booking a laser or buying a stronger cream. The next step is a dermatologist assessment that confirms melasma pattern, depth clues, triggers, skin readiness, and a safe sequence for Indian skin.
- 30-45 minute dermatologist consultation
- Melasma pattern mapping and depth assessment
- Wood’s lamp or dermoscopy where indicated
- Product audit, sunscreen correction, and trigger review
- Starting from ₹1,999 — final cost explained after assessment
Book your melasma consultation
By submitting this form, you agree to be contacted by our team. This form does not create a doctor-patient relationship.